This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

WEB REGISTRATION CLOSES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Sebastian Palluk, Ph.D.
Chief Technology Officer at Ansa Biotechnologies
Speaker

Profile

Sebastian Palluk is a pioneer in enzymatic DNA synthesis who co-authored the first paper describing an enzymatic method for de novo DNA synthesis in Nature Biotechnology (2015). He co-founded Ansa Biotechnologies to commercialize the technology and serves as the company’s chief technology officer. Sebastian is named as a co-inventor on more than 10 patent families related to enzymatic DNA synthesis. Under his leadership, Ansa Biotechnologies has set new records for lengths of synthesized oligonucleotides, including a 1,005-base-long oligo the team reported in 2023. Sebastian was awarded his PhD from the Technical University of Darmstadt for the work he performed on polymerase-nucleotide conjugates at the Lawrence Berkeley National Laboratory. He received a master's degree in biomolecular engineering from the Technical University of Darmstadt.

Agenda Sessions

  • Pushing the Boundaries of Nucleic Acid Synthesis

    11:15am